Global Cancer Gene Therapy Market Research Report 2017

  • KMI-168276
  • Jun 2017
  • 109 pages
  • Healthcare
In this report, the global Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Gene Therapy in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Cancer Gene Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Cell Genesys
Advantagene
GenVec
BioCancell
Celgene and Epeius Biotechnologies
Introgen Therapeutics
ZIOPHARM Oncology
MultiVir
Shenzhen SiBiono GeneTech
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Insertion of new genes into the body
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Cancer Gene Therapy for each application, including
Hospitals
Diagnostic Centres
Drug Manufacturers
Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.
Global Cancer Gene Therapy Market Research Report 2017
1 Cancer Gene Therapy Market Overview
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Cancer Gene Therapy Segment by Type (Product Category)
1.2.1 Global Cancer Gene Therapy Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Cancer Gene Therapy Production Market Share by Type (Product Category) in 2016
1.2.3 Insertion of new genes into the body
1.2.4 Other
1.3 Global Cancer Gene Therapy Segment by Application
1.3.1 Cancer Gene Therapy Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Diagnostic Centres
1.3.4 Drug Manufacturers
1.3.5 Research Institutes
1.4 Global Cancer Gene Therapy Market by Region (2012-2022)
1.4.1 Global Cancer Gene Therapy Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cancer Gene Therapy (2012-2022)
1.5.1 Global Cancer Gene Therapy Revenue Status and Outlook (2012-2022)
1.5.2 Global Cancer Gene Therapy Capacity, Production Status and Outlook (2012-2022)

2 Global Cancer Gene Therapy Market Competition by Manufacturers
2.1 Global Cancer Gene Therapy Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Cancer Gene Therapy Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Cancer Gene Therapy Production and Share by Manufacturers (2012-2017)
2.2 Global Cancer Gene Therapy Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cancer Gene Therapy Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Gene Therapy Market Competitive Situation and Trends
2.5.1 Cancer Gene Therapy Market Concentration Rate
2.5.2 Cancer Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Gene Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Cancer Gene Therapy Capacity and Market Share by Region (2012-2017)
3.2 Global Cancer Gene Therapy Production and Market Share by Region (2012-2017)
3.3 Global Cancer Gene Therapy Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Cancer Gene Therapy Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Cancer Gene Therapy Consumption by Region (2012-2017)
4.2 North America Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.4 China Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.7 India Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

5 Global Cancer Gene Therapy Production, Revenue (Value), Price Trend by Type
5.1 Global Cancer Gene Therapy Production and Market Share by Type (2012-2017)
5.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Gene Therapy Price by Type (2012-2017)
5.4 Global Cancer Gene Therapy Production Growth by Type (2012-2017)

6 Global Cancer Gene Therapy Market Analysis by Application
6.1 Global Cancer Gene Therapy Consumption and Market Share by Application (2012-2017)
6.2 Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Cancer Gene Therapy Manufacturers Profiles/Analysis
7.1 Cell Genesys
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cancer Gene Therapy Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Cell Genesys Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Advantagene
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cancer Gene Therapy Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Advantagene Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 GenVec
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cancer Gene Therapy Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 GenVec Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 BioCancell
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cancer Gene Therapy Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 BioCancell Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Celgene and Epeius Biotechnologies
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cancer Gene Therapy Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Celgene and Epeius Biotechnologies Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Introgen Therapeutics
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cancer Gene Therapy Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Introgen Therapeutics Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 ZIOPHARM Oncology
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cancer Gene Therapy Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 ZIOPHARM Oncology Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 MultiVir
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cancer Gene Therapy Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 MultiVir Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Shenzhen SiBiono GeneTech
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cancer Gene Therapy Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview

8 Cancer Gene Therapy Manufacturing Cost Analysis
8.1 Cancer Gene Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Gene Therapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Cancer Gene Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Cancer Gene Therapy Market Forecast (2017-2022)
12.1 Global Cancer Gene Therapy Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Cancer Gene Therapy Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Cancer Gene Therapy Price and Trend Forecast (2017-2022)
12.2 Global Cancer Gene Therapy Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cancer Gene Therapy Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cancer Gene Therapy Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

   Global Healthcare IT Consulting Market By Type (Strategy, Project Management, Integration, Migration, Security, Risk assessment, Analytics, BPM, Regulatory), End User (Hospitals, IDN, ACC, Home, Payer, Public, Private) and Region (North America, Asia Pacific, Europe, Latin America, Rest of the World) Market Size, Status and Forecast to 2025

   Global Life Science Analytics Market By Type (Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, SCM), Component (Software, Service), Delivery (on premise, cloud) and End user (Pharmaceutical, Biotechnology, Medical Device, CRO), and Region (North America, Asia Pacific, Europe, Latin America, Rest of the World) Market Size, Status and Forecast to 2025

   Global ECG Cable and ECG Lead wires Market By Material (Thermoplastic Elastomer, TPU), Usability (Reusable, Disposable), ECG Lead wires by Machine Type (3 lead, 5 lead), Patient Care Setting (Long term care facilities, Home care) and Regional Market Size, Status and Forecast to 2025

   Global Defibrillators Market By Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) and Regional Market Size, Status and Forecast to 2025

   Global Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemi-luminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) and Regional Market Size, Status and Forecast to 2025

   Global Atrial Fibrillation Surgery Market By Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) and Regional Market Size, Status and Forecast to 2025

   Global Anatomic Pathology Market By Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) and Regional Market Size, Status and Forecast to 2025

   Global Blood Group Typing Market By Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User and Regional Market Size, Status and Forecast to 2025

   Global Blood Screening Market By Technology (Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assay, Next-Generation Sequencing), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) and Regional Market Size, Status and Forecast to 2025

   Global Coagulation/Hemostasis Analyzer Market By Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) and Regional Market Size, Status and Forecast to 2025

Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Head-Sales
mansing
Mansingh Surve
Manager-Sales
Diksha
Diksha Singh Rathore
Team Lead-Sales
view